CRISPR-based assay could revolutionize diagnosis of Mycobacterium avium complex NTM infections
A recent study carried out by researchers at Tulane University and published in the American Journal of Respiratory and Critical Care Medicine unveiled a novel diagnostic tool that can identify Mycobacterium avium complex (MAC) nontuberculous mycobacterial (NTM) infections in as little as two hours.